Related by context. Frequent words. (Click for all words.) 65 Panzem R 63 TOCOSOL Paclitaxel 63 IND submission 63 PEG SN# 62 KNS # 62 phase IIa clinical 62 refractory chronic lymphocytic 61 Factor VIIa 61 Neuradiab 61 IIa trial 61 MOZOBIL 61 elotuzumab 61 forodesine 60 deforolimus 60 Phase Ib clinical 60 INCB# [001] 60 IMC #B 60 Allovectin 7 R 60 Phase IIB 60 proteasome inhibitor 60 Daclizumab 60 Peptimmune 60 atacicept 60 Chemokine 59 nonclinical studies 59 Initiate Phase 59 FDA approvable letter 59 Asentar 59 KRN# 59 Phase Ib II 59 Mipomersen 59 FavId 59 Fibrillex TM 59 Pivotal Phase III 59 phase IIb clinical 59 phase Ib 59 Guanilib 59 Celator 59 Cethrin 59 liposomal formulation 59 Urocidin 59 ixabepilone 59 eniluracil 59 Adventrx 59 vosaroxin 58 Addrenex 58 TOLAMBA 58 GVAX R 58 Presents Positive 58 CTCE 58 ThermoDox R 58 Ixempra 58 Hybridon 58 dacetuzumab 58 ISTODAX 58 GGF2 58 metastatic hormone refractory 58 MORAb 58 liprotamase 58 targeting CD# 58 Chemokine Therapeutics 58 ONTAK 58 ViaCyte 57 Argatroban 57 Tesetaxel 57 Combidex 57 MEK inhibitor 57 PMA submission 57 Proxinium TM 57 AVAX 57 M Enoxaparin 57 Metastatic Melanoma 57 anticancer compound 57 Sulonex 57 R sorafenib tablets 57 preclinical toxicology 57 Cloretazine R VNP#M 57 Genaera Corporation 57 JAK1 57 orally bioavailable 57 NASDAQ LGND 57 DDP# 57 AMD# [003] 57 peginesatide 57 Vilazodone 57 ATL# [001] 57 Azedra 57 DAVANAT ® 57 forodesine HCl 57 Orphan Drug status 57 Protexia R 57 Phase Ia 57 ASONEP 57 FDA Accepts 57 Bicifadine 57 SCOLR Pharma 57 ICA # 57 Phase 1b trial 57 epothilone 57 Phase IIb trials 57 ganetespib